Fingerprint
Dive into the research topics of 'A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: A gynecologic oncology group trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically